Clinical Trial Update: "Efficacy and Safety of Infliximab-biosimilar (Inflectra) Compared to Infliximab-innovator (Remicade) in Patients With Inflammatory Bowel Disease in Remission: the SIMILAR Trial" [Phase 4]

View source ↗

Summary

Phase 4 trial comparing the infliximab biosimilar Inflectra to Remicade in inflammatory bowel disease patients in remission; current status/results are not yet …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Crohn Disease
• Ulcerative Colitis

Drugs mentioned

• INFLECTRA (infliximab-dyyb)
• Remicade (infliximab)

Snippet

Sponsor: Onze Lieve Vrouwe Gasthuis | Conditions: Colitis, Ulcerative, Crohn's Disease | Phase 4 | Status: UNKNOWN